Abstract
BackgroundWe previously demonstrated that FSTL1 is a key driver of cancer stemness and metastasis accompanied by immune exhaustion and dysfunction leading to anti-PD1 resistance in a variety of cancers, including...
Paper version not known (
Free)
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have